Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients

被引：33

作者：

Ferra, Christelle ^{[1
]}

Sanz, Jaime ^{[2
]}

Diaz-Perez, Miguel-Angel ^{[3
]}

Morgades, Mireia ^{[1
]}

Gayoso, Jorge ^{[4
]}

Cabrera, Jose-Rafael ^{[5
]}

Villaescusa, Teresa ^{[6
]}

Sampol, Maria-Antonia ^{[7
]}

Fernandez-Aviles, Francesc ^{[8
]}

Solano, Carlos ^{[9
]}

Ortin, Miguel ^{[10
]}

Duarte, Rafael ^{[11
]}

Cuesta, Marian ^{[12
]}

Heras, Inmaculada ^{[13
]}

de la Serna, Javier ^{[14
]}

Moraleda, Jose-Maria ^{[15
]}

Barrenetxea, Cristina ^{[16
]}

Gonzalez-Vicent, Marta ^{[3
]}

Sanz, Guillermo ^{[2
]}

Ribera, Josep-Maria ^{[1
]}

机构：

[1] Hosp Badalona Germans Trias & Pujol, Dept Hematol, Inst Catala Oncol, Josep Carreras Res Inst, Badalona, Spain

[2] Hosp La Fe, Dept Hematol, E-46009 Valencia, Spain

[3] Hosp Nino Jesus, Dept Hematol, Madrid, Spain

[4] Hosp Gen Gregorio Maranon, Dept Hematol, Madrid, Spain

[5] Hosp Puerta Hierro, Dept Hematol, Madrid, Spain

[6] Hosp Univ Salamanca, Dept Hematol, Salamanca, Spain

[7] Hosp Son Espases, Dept Hematol, Palma de Mallorca, Spain

[8] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain

[9] Hosp Clin Univ, Dept Hematol, Valencia, Spain

[10] Hosp Santa Creu & Sant Pau, Dept Hematol, Barcelona, Spain

[11] Hosp Duran & Reynals, Dept Hematol, Inst Catala Oncol, Lhospitalet De Llobregat, Spain

[12] Hosp Carlos Haya, Dept Hematol, Malaga, Spain

[13] Hosp Morales Meseguer, Dept Hematol, Murcia, Spain

[14] Hosp 12 Octubre, Dept Hematol, Madrid, Spain

[15] Hosp Virgen Arreixaca, Dept Hematol, Murcia, Spain

[16] Hosp Valle De Hebron, Dept Hematol, Barcelona, Spain

来源：

LEUKEMIA & LYMPHOMA | 2015年 / 56卷 / 03期

关键词：

Graft failure; hematopoietic stem cell transplant; outcome; infectious complications; CORD BLOOD TRANSPLANTATION; PERIPHERAL-BLOOD; BONE-MARROW; ENGRAFTMENT; FLUDARABINE; REJECTION; RELAPSE; GVHD;

D O I：

10.3109/10428194.2014.930849

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Strategies for reversing graft failure (GF) after allogeneic stem cell transplant (SCT) depend on the options available in each situation. GF was reported in 16 Spanish institutions from January 2006 to July 2011. Primary GF was defined as an absolute neutrophil count (ANC) > 0.5 x 10(9)/L not reached by day + 28 after SCT from peripheral blood (PB) or bone marrow (BM) progenitors and by day + 42 after SCT from unrelated cord blood (UCB) progenitors. Secondary GF was defined as a recurrent ANC < 0.5 x 10(9)/L. Eighty-nine patients with GF were reported, and 80 patients received a second SCT. The 5-year survival probability was 31% (95% confidence interval [CI]: 18-44%), and the incidences of non-relapse mortality and relapse estimated by competing risks were 47% (95% CI: 36-58%) and 21% (95% CI: 4-28%). The strategy adopted to treat GF was heterogeneous, and no approach could be unequivocally recommended for this situation. The prognosis of patients with GF was poor even after successful recovery from GF.

引用

页码：656 / 662

页数：7

共 50 条

[1] Graft failure after allogeneic hematopoietic stem cell transplantation
Ozdemir, Zehra Narli
Bozdag, Sinem Civriz
TRANSFUSION AND APHERESIS SCIENCE, 2018, 57 (02) : 163 - 167
[2] Autologous Stem Cell Rescue for Graft Failure of Second Allogeneic Stem Cell Transplant After Engraftment of Primary Allogeneic Transplant
Watanabe, Atsushi
Inukai, Takeshi
Akahane, Koshi
Somazu, Shinpei
Oshiro, Hiroko
Goi, Kumiko
Koizumi, Keiichi
Harii, Norikazu
Matsuda, Kenichi
Sugita, Kanji
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2019, 17 (02) : 281 - 283
[3] Graft failure after allogeneic hematopoietic stem cell transplantation in pediatric patients with acute leukemia: autologous reconstitution or second transplant?
Rostami, Tahereh
Rostami, Mohammad Reza
Mirhosseini, Amir Hossein
Mohammadi, Saeed
Nikbakht, Mohsen
Alemi, Hediyeh
Khavandgar, Naghmeh
Rad, Soroush
Janbabai, Ghasem
Mousavi, Seied Asadollah
Kiumarsi, Azadeh
Kasaeian, Amir
STEM CELL RESEARCH & THERAPY, 2024, 15 (01)
[4] The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease
Svenberg, Petter
Wang, Tengyu
Uhlin, Michael
Watz, Emma
Remberger, Mats
Ringden, Olle
Mattsson, Jonas
Uzunel, Mehmet
CLINICAL TRANSPLANTATION, 2019, 33 (06)
[5] Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors
Alcazer, Vincent
de Latour, Regis Peffault
Ader, Florence
Labussiere-Wallet, Helene
BULLETIN DU CANCER, 2019, 106 (06) : 574 - 583
[6] Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia
Onishi, Yasushi
Mori, Takehiko
Kako, Shinichi
Koh, Hideo
Uchida, Naoyuki
Kondo, Tadakazu
Kobayashi, Takeshi
Yabe, Hiromasa
Miyamoto, Toshihiro
Kato, Koji
Suzuki, Ritsuro
Nakao, Shinji
Yamazaki, Hirohito
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (12) : 2137 - 2142
[7] Primary Graft Failure After Umbilical Cord Blood Transplant Rescued by Parental Haplocompatible Stem Cell Transplantation
Dvorak, Christopher C.
Gilman, Andrew L.
Horn, Biljana
Cowan, Morton J.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (04) : 300 - 303
[8] Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients
Woodard, P
Tong, X
Richardson, S
Srivastava, DK
Horwitz, EM
Benaim, E
Geiger, T
Hale, G
Leung, W
Turner, V
Yusuf, U
Cunningham, J
Handgretinger, R
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (12) : 955 - 959
[9] Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia
Devillier, Raynier
Crocchiolo, Roberto
Etienne, Anne
Prebet, Thomas
Charbonnier, Aude
Fuerst, Sabine
El-Cheikh, Jean
D'Incan, Evelyne
Rey, Jerome
Faucher, Catherine
Blaise, Didier
Vey, Norbert
LEUKEMIA & LYMPHOMA, 2013, 54 (06) : 1228 - 1234
[10] Poor graft function after T cell-depleted allogeneic hematopoietic stem cell transplant
Reich-Slotky, Ronit
Al-Mulla, Naima
Hafez, Rania
Segovia-Gomez, Javier
Goel, Ruchika
Mayer, Sebastian
Phillips, Adrienne
Shore, Tsiporah B.
Hsu Jing-Mei
Hsu, Yen-Michael Sheng
Vasovic, Ljiljana V.
Cushing, Melissa M.
Gergis, Usama
LEUKEMIA & LYMPHOMA, 2020, 61 (12) : 2894 - 2899

← 1 2 3 4 5 →